Antidiarrheal Drugs

Rehydrate, classify, then suppress safely

Symptom control comes after the alarm-feature screen.

First replace fluid and electrolytes and assess severity. Hypotension, severe dehydration, peritoneal signs, ileus, abdominal distension, high fever, blood, severe inflammatory disease, or toxic megacolon change the plan immediately.

Next separate uncomplicated watery diarrhea from invasive infection, inflammatory colitis, medication toxicity, bile acid diarrhea, malabsorption, and endocrine or neuroendocrine secretion. The same stool frequency can arise from very different mechanisms.

Only then choose a targeted agent and a short reassessment interval. Failure to improve, new blood or fever, distension, or persistent symptoms should stop reflex redosing and reopen the diagnosis.

The site of action explains both benefit and interaction

Keep the target in the lumen when the problem is luminal, and do not ignore what else gets bound.

Loperamide and diphenoxylate act in the enteric nervous system to slow propulsion throughout the bowel. That improves absorption in uncomplicated diarrhea but also increases contact time between diseased mucosa and pathogens, toxins, or inflammatory contents.

Cholestyramine, colestipol, and colesevelam remain in the lumen and bind bile acids that spill into the colon after ileal dysfunction or selected post-cholecystectomy states. They can also bind other medicines and reduce absorption of fat-soluble vitamins.

Octreotide acts systemically at somatostatin receptors to reduce endocrine secretion. It fits VIPoma, carcinoid syndrome, and selected refractory secretory states, not ordinary osmotic or invasive diarrhea.

Opioid and cardiac toxicity are not theoretical

The gut selectivity of loperamide disappears when exposure becomes extreme.

Very high loperamide doses or interacting drugs that increase absorption or reduce metabolism can cause QT prolongation, torsades de pointes, ventricular arrhythmias, syncope, and cardiac arrest. Misuse may occur during attempts to self-treat opioid withdrawal.

Diphenoxylate overdose can produce respiratory depression and central opioid toxicity, while atropine adds tachycardia, hyperthermia, mydriasis, urinary retention, dry skin, and delirium. Toxicity can be delayed because gut motility is slowed.

Bismuth can cause benign black stool and tongue but also salicylate toxicity or, with prolonged excessive exposure, neurotoxicity. A black stool after bismuth still requires clinical distinction from melena when symptoms or hemodynamics suggest bleeding.

A gut opioid at the right dose can become a heart and brain toxin at the wrong dose.

Treat the mechanism, not the word diarrhea

Five drug lanes solve different physiologic problems.

Loperamide activates peripheral intestinal mu-opioid receptors, reduces acetylcholine release in the myenteric plexus, slows propulsion, increases contact time for fluid absorption, and raises anal sphincter tone. P-glycoprotein limits central nervous system entry at recommended doses.

Diphenoxylate is an opioid that slows motility but can produce central opioid effects at high exposure. Atropine is added to discourage deliberate overuse and creates anticholinergic toxicity when excess tablets are taken.

Bismuth subsalicylate coats mucosa and adds antisecretory, anti-inflammatory, and antimicrobial activity. Bile acid sequestrants bind irritant bile acids in the lumen, while octreotide suppresses hormone-mediated secretion in selected high-output syndromes.

Motility drugs slow the conveyor; bile binders remove the irritant; octreotide turns down the secretory signal.

Dose ceilings are safety barriers

Crossing the labeled range changes the drug from symptom control to poisoning risk.

The maximum approved adult loperamide dose is 8 mg per day for over-the-counter use and 16 mg per day for prescription use. Higher doses, especially with interacting drugs, are linked to lethal arrhythmias.

The initial adult Lomotil label dose is two tablets four times daily, for a maximum of 20 mg diphenoxylate per day. Atropine discourages overuse but does not make overdose safe.

When over-the-counter treatment has not improved acute diarrhea within 48 hours, stop reflex dosing and seek evaluation. Duration, hydration, fever, blood, distension, and pain matter more than achieving zero stools.

Eight OTC, 16 prescription, and 48 hours are guardrails, not targets.

Know when not to slow the bowel

A contraindication is a mechanism warning, not a memorized exception list.

Avoid loperamide and diphenoxylate when inhibition of peristalsis is dangerous: bloody or febrile invasive diarrhea, suspected C. difficile colitis, acute dysentery, ileus, marked distension, acute severe inflammatory colitis, or toxic megacolon.

Bile acid sequestrants help documented or strongly suspected bile acid diarrhea, but constipation, bloating, medication binding, and worsening steatorrhea after extensive ileal loss can limit them. They do not treat active Crohn inflammation.

Octreotide is reserved for selected severe secretory diarrhea after the driver is identified. It can cause gallstones, glucose disturbance, bradycardia, and malabsorption, so escalation to it requires a reason and a monitoring plan.